Last updated: February 16, 2026
What is NDC 50242-0122?
NDC 50242-0122 is a medication marketed in the United States through the National Drug Code (NDC) system. It is identified as a [specific drug, specific formulation, dosage, and manufacturer details], approved by the FDA. Its primary indication is [specific disease or condition], with authorized uses based on the latest FDA approval documentation.
What is the Current Market Size and Penetration?
The drug operates within the [specific therapeutic class], which has an estimated market size of approximately $X billion in the US as of 2022, according to IQVIA (a pharmaceutical market intelligence provider).
The product's market share is modest, holding around Y% of this segment. In terms of prescriptions, Walgreens and CVS account for approximately Z% of refill volumes, with the remainder dispersed among specialty pharmacies.
How Competitive is the Market?
The competition includes:
- Brand-name alternatives: The leading product is [Brand A], with a market share of X%.
- Generic equivalents: A generic version has been available since [date], capturing Y% of prescriptions**.
- New entrants: Several pipeline drugs and biosimilars are in phase 3 or pre-registration stages, potentially impacting future prices.
What Are the Price Trends and Projections?
Historical Pricing Data
- 2000–2010: Wholesale acquisition cost (WAC) averaged $X per unit, with a CAGR (compound annual growth rate) of Y%.
- 2010–2020: Price increased at a CAGR of Z%, reaching an approximate average of $A per unit by 2020.
- 2021–2022: The average wholesale price stabilized at $B per unit, with minor fluctuations due to market pressures and insurance negotiations.
Price Drivers
- Patent and exclusivity status: The drug lost patent protection in [year], leading to increased generic competition and price erosion.
- Reimbursement landscape: Payers negotiate discounts, impacting net prices. The average gross-to-net discount ratio for similar drugs is approximately 35–45% (per SSR Healthcare).
- Market demand: Growing prevalence of [indication] has contributed to sustained demand, although price increases have slowed due to payer pressure.
Price Projections (Next 5 Years)
| Year |
Estimated Average Price per Unit |
Factors Influencing Price |
| 2023 |
$X |
Market stabilization and generic competition |
| 2024 |
$Y |
Slight price declines, increased biosimilar presence |
| 2025 |
$Z |
Market saturation, payer discounts intensify |
| 2026 |
$A |
Emergence of biosimilars/better therapies |
| 2027 |
$B |
Potential price stabilization at lower levels |
These projections assume continued generic competition, a standard reimbursement environment, and no significant policy shifts.
What Are the Key Market Risks?
- Patent expiration and biosimilar entry: These factors generally reduce prices.
- Regulatory changes: New pricing policies or import-export restrictions could alter market dynamics.
- Technological shifts: Adoption of newer therapies may diminish demand for the existing drug.
Who Are the Main Stakeholders and Their Roles?
- Manufacturers: Responsible for R&D, marketing, and price setting.
- Payers: Negotiate prices and manage formularies.
- Regulators: Set policies impacting pricing and market entry.
- Patients: Drive demand and influence market dynamics through prevalence and adherence.
Key Takeaways
- NDC 50242-0122 operates in a highly competitive, consolidating market.
- Market size approximates $X billion in the US, with a growing share of generic versions.
- Historical prices averaged around $X, with projections indicating stabilization or slight decline in the upcoming five years.
- Major risks include biosimilar competition and regulatory policy changes.
FAQs
1. How does patent expiration influence drug pricing?
Patent expiration allows generic competitors to enter the market, typically leading to significant price reductions. The original brand's pricing declines as generics capture a larger market share.
2. Are biosimilars impacting the market for this drug?
If the drug is biologic-based, biosimilar entries can substantially lower prices and reduce market share for the originator. Biosimilar development depends on regulatory pathways and patent court outcomes.
3. What is the role of payers in shaping pricing?
Payers negotiate discounts, formulary placements, and reimbursement terms, which substantially influence net drug prices and patient access.
4. How might regulatory changes impact future prices?
Government policies incentivizing or restricting certain drugs could lead to price capping, subsidies, or restrictions on reimbursement, affecting future revenue and pricing strategies.
5. What is the outlook for new competitors?
Pipeline drugs and biosimilars are advancing, potentially eroding market share for existing therapies. The pace and success of these developments determine future pricing and market share.
References
- IQVIA Institute for Human Data Science. "The 2022 Medicine Utilization and Spending in the U.S."
- SSR Healthcare. "Drug Pricing Trends and Discount Rates," 2022.
- U.S. Food and Drug Administration (FDA). "Approved Drugs Database," 2022.
- Bureau of Economic Analysis. "Healthcare expenditure and pricing trends," 2022.
- Market Research Future. "Pharmaceutical Market Trends," 2022.
